Arts, Environment, Government, Health, Science, Society, United Nations

How Can We Deal With Global Population Growth?

POPULATION GROWTH

Intro: With population numbers projected to continue to swell over the course of the twenty-first century, there are some pressing questions that remain unresolved. We should turn to science in search of solutions to Earth’s depleting space and resources.

THE subject of global population growth can be an emotive one, and many accounts of rising populations are accompanied by dire warnings of impending catastrophe. Concern about population growth is by no means a modern phenomenon, though. In 1798, the British cleric Thomas Malthus published An Essay on the Principles of Population, in which he addressed the potential problems that could develop due to the rapidly rising population in Britain at that time, a consequence of the Industrial Revolution. He argued that populations had the capacity to grow more quickly than food production, writing, “The power of population is so superior to the power of the earth to produce subsistence for man, that premature death must in some shape or other visit the human race.” It would become a highly influential concept and one that would reach beyond demography alone – acknowledged, for instance, by Charles Darwin as having been one of the key ideas that led to his theory of evolution by natural selection, which described competition for resources as being one of the driving forces behind evolution.

The Population Bomb

In 1968, the American entomologist and environmentalist Paul Ehrlich wrote in Malthusian terms in The Population Bomb of an upcoming catastrophe, in which many millions of people would die of starvation. Though not the first publication to examine the so-called “population problem”, its popularity introduced the issue to a much wider audience. It was followed in 1972 by the even more widely read The Limits to Growth, a collaborative report commissioned by the political think tank the Club of Rome. Both works were relatively sober, informed assessments, but were followed by a range of sensationalist books and articles, containing various prophecies of doom – which remain a feature of environmental discussion today.

Paul Ehrlich

Paul Ehrlich, whose book brought the population problem to the attention of a much wider audience.

In The Population Bomb, Ehrlich wrote that the Earth could support two billion people before disaster ensued – a figure that had already been exceeded by more than a billion at the time the book was published. Now, almost 50 years later, the predicted catastrophic collapse has not occurred (at least not yet anyway). In July 2015, the Population Division of the United Nations Department of Economics and Social Affairs in New York released the annual revision to its 2010 population census, providing estimates of the global population over the course of this century. According to this, the global population was 7.3 billion in 2015, and was expected to continue growing, reaching 10 billion by the middle of the century and 11.2 billion by 2100, by which time the rate of growth is expected to have slowed – before stabilising and perhaps beginning to fall.

By no means do all demographers agree with the UN figures. The wide variation between experts’ population predictions is a consequence of the number of unknown factors involved, and because in reality people rarely behave exactly as expected. But, if we take the UN figures as a reasonable estimate, over the next three to four decades an additional 3 billion people will inhabit the world, and the total figure will be five times higher than Paul Ehrlich’s estimated carrying capacity of the Earth.

The Impact of Science

One of the ways science has helped to avert potential disasters is through agricultural research aimed at increasing food produce. One of the best-known examples of this is the Green Revolution on the Indian subcontinent, which began in the 1960s – a period when India and Pakistan were experiencing population booms that appeared to be outstripping the capacity of the region’s agriculture to produce enough food for everyone. New varieties of high-yielding wheat, developed by the American agronomist Norman Borlaug at a research station in Mexico, were transferred to the subcontinent, greatly increasing agricultural productivity and averting the potential for widespread famine.

Subsequent research produced new varieties of other staple crops, including rice, and these, together with the use of new technologies in the shape of farm machinery, fertilisers and pesticides, have had a dramatic impact on the amount of food produced – even if these technical advancements can come with social and environmental costs. It has become clear that new technology on its own is not a complete solution, though, and extreme poverty can lead to people remaining malnourished despite there being no local food shortages, through not having land to grow crops themselves or the means to buy enough food.

Science can also help in the field of healthcare, through the development of medical technology and drugs that address the particular problems causing high levels of child mortality, which are often encountered in those parts of the world where high rates of population growth occur. When such technologies are combined with more widely available healthcare services, the resulting reduction in child mortality often leads to lower rates of population growth. Put simply, women have fewer children in places where those children are more likely to survive into adulthood, and so population numbers gradually begin to stabilise.

Hope For The Future

The UN figures show that growth rates have already slowed down in many parts of the world. Europe, North and South America and Oceania now show no growth at all, and nor does much of Asia, with the notable exceptions of India and Pakistan. About three-quarters of the population growth set to occur over the course of this century is projected to be on the African continent, and this rise will almost all be as a consequence of people living longer, rather than an increase in the number of children being born. This statistic is key to gaining an understanding of how population growth should slow down and eventually stabilise in the future; improvements in healthcare initially lead to a rapid rise in life expectancy, so, rather than a rising population being caused by more children being born, it is actually a consequence of there being an increased number of older people. Over time, the initial rapid increase in life expectancy will tend to level off and, at this point, the population will stop rising as well.

 

IN the future, then, there will be many more people in the world, and it does appear that population growth is set to continue in the long term. The challenges ahead are to grow enough food, to alleviate extreme poverty and to provide adequate healthcare for the entire global population.

Alternative Theories

UNLIKE the doom merchants who have until recently dominated the public debate on population growth, the Swedish doctor and statistician Hans Rosling describes himself as a possibilist, believing not only that the Earth can support 11 billion people, but that all of them can enjoy a good quality of life. He appears to be on a mission to make population statistics entertaining as well as informative, making use of dynamic graphics to illustrate his lectures and enlivening proceedings with plenty of comical jokes, mostly at his own expense.

To take just one example of many, Rosling describes the washing machine as being one of the great inventions of the twentieth century because of the impact it has had on freezing women from domestic drudgery, allowing them the time to do other things, like going to university or by seeking an alternative career. As he points out, the statistics show that as women become better educated, they gain more control over their lives – over the age at which they start a family and the number of children they have. Where they have the choice, many women opt to have children later in life than their mothers and grandmothers did, and often prefer to have two or three children rather than five or six. This phenomenon has been seen around the world and has often occurred over the course of a single generation. Rosling is not trying to say that this is entirely caused by the washing machine, rather using it to illustrate the point that the empowerment of women has been one of the driving forces behind the observed reduction in population growth rates.

Standard
Health, Medical, Research, Science

Brain health linked to how young or old you feel

NEUROSCIENCE STUDY

Besides improving your physical and mental health, feeling younger can also slow down the rate of brain ageing, finds a study.

THE young at heart often insist you are only as old as you feel.

A newly released study has proved they are right, finding that those who feel younger than they are show fewer signs of brain ageing.

Neuroscientists who gave a group of people aged 59 to 84 MRI scans found that those who said they felt younger had more grey matter in their brains and did better in memory tests.

The researchers suggested that those who feel their age or older have picked up on small cognitive changes in their brain, such as mild memory loss. The study, carried out by the University of Seoul in South Korea, is the first to link how old people feel with the physical signs of brain ageing.

Co-author Dr Jeanyung Chey said: “We found people who feel younger have the structural characteristics of a younger brain.

“Importantly, this difference remains robust even when other possible factors – including personality, subjective health, depressive symptoms or cognitive functions – are accounted for. If somebody feels older than their age, it could be a sign for them to evaluate their lifestyle, habits and activities that could contribute to brain ageing and take measures to better care for their brain health.”

The researchers asked 68 healthy people whether they felt older or younger than they were, or whether they felt their age. When their brains were scanned, those who felt younger had more grey matter in key regions such as the hippocampus which is linked to memory.

The scans showed their brains had actually aged less than those of people who felt older, as grey matter tends to decline with age.

The youthful-feeling group also did better in memory tests, including tasks such as recalling details from a story 15 to 30 minutes after hearing it. The researchers suggested that those who feel older may be able to sense the ageing process in their brain as their loss of grey matter may make cognitive tasks more challenging.

Another possibility is that those who feel younger are more likely to lead a more physically and mentally active life, which could cause improvements in brain health. Previous studies have suggested that asking people how old they feel can predict if they will develop dementia, become frail or be taken to hospital. Those who feel older than their age are also more likely to be overweight and suffer illnesses associated with being obese.

Dr Chey, whose study was first published in the journal Frontiers in Aging Neuroscience, said: “Why do some people feel younger or older than their real age?

“Some possibilities include depressive states, personality differences or physical health.

“However, no one had investigated brain ageing processes as a possible reason for differences in subjective age.”

The results suggest that feeling older than one’s age may reflect relatively faster ageing brain structures. Those who feel younger have better-preserved and healthier brain structures.

Some of the biggest changes in grey matter based on age perception were found in the inferior pre-frontal cortex, which helps in suppressing irrelevant information. Loss in this region could cause age-related problems in tasks requiring focus and concentration.

Standard
Health, Medical, Research, Science, Society

What can we do about antibiotic resistance?

ANTIBIOTICS

Intro: In 2014, the World Health Organisation (WHO) stated that antibiotic resistance was “happening right now in every region of the world” – leaving us at risk of entering a “post-antibiotic era”, where common infections could once again become fatal.

The WHO’s first global report on antibiotic resistance may sound alarmist, but it reflects the crucial role antibiotics have played in treating microbial diseases and infections since first becoming available in the 1930s.

Antibiotics were discovered in 1928 by the Scottish bacteriologist Alexander Fleming while he was working at the St Mary’s Hospital Medical School in London. During the First World War he had served as a medic in military hospitals behind the Western Front, where he witnessed the death of many soldiers from wounds that had become septic as a consequence of bacterial infections. After the war, Fleming directed his research efforts towards finding better ways of dealing with such infections and, according to his later account, discovered penicillin through chance and luck. A fungal mould of the genus Penicillium had infected a Petri dish containing a bacterial culture, after the spores had apparently blown into Fleming’s laboratory through a window that had accidentally been left open. As he was about to throw the Petri dish away, Fleming noticed that the bacteria around the mould had been killed, leading him to isolate the active substance produced by the mould, which he named penicillin.

A Medical Revolution

It took ten years for any serious work to start on developing penicillin into a usable antibiotic and, in the meantime, the German pharmaceutical company Bayer developed the sulphonamide antibacterial drugs, sold under the name of Prontosil. The beginning of the Second World War led to renewed interest in penicillin, and a team at Oxford University – led by Howard Florey and including the Jewish, German-born Ernst Chain, who had fled Germany in 1933 to escape persecution – developed a method of producing penicillin for medicinal use. For this work they, together with Fleming, were later awarded the Nobel Prize for medicine.

Making enough penicillin for armies during the Second World War proved difficult until deep fermentation was developed in America, coming just in time to provide sufficient supplies for the armed forces during the invasion of Normandy in June 1944. After the war, further research improved penicillin, and other antibiotics were developed, leading to a medical revolution that, coupled with the widespread use of vaccines, has dramatically reduced the impact of fatal or debilitating diseases and infections.

Growing Resistance

Almost as soon as he began to work on penicillin, Alexander Fleming recognised the potential for bacteria to develop resistance, because of the capacity such microbes have to replicate very rapidly, providing the opportunity for evolution to occur. Should a mutation arise which confers resistance, it can spread quickly – facilitated by the further use of antibiotics, because these would then wipe out any non-resistant bacteria that would otherwise compete with the resistant strain. Despite repeated warnings by Fleming and many others not to misuse antibiotics, it quickly became common practice for doctors to prescribe them for a much wider range of illnesses than they should have, often simply because patients demanded them.

Today, antibiotics are still being given to patients who have colds or flu – viral infections against which such treatments are ineffective – and are also widely used in veterinary medicine as a preventative measure in livestock farming rather than as a treatment for a specific disease. In some countries, antibiotics are also used as growth promoters in livestock, it having been found that animals treated in this way often perform better. About two-thirds of all antibiotics are now used on farms, and while these are different from the ones used to treat people, such use can nevertheless result in a build-up of resistance, which has the potential through genetic mutation to transfer to medicinal human antibiotics.

Resistance will build up in bacteria even where antibiotics are used responsibly, but the more they are used, the quicker this will happen, so it is vitally important that they are not overprescribed or misused in livestock farming. Unfortunately, this advice has not always been followed, leading to a number of infectious diseases becoming increasingly difficult to treat. Some of the best-known examples are those particularly associated with hospitals, known by most people as “superbugs”, such as MRSA (methicillin-resistant Staphylococcus aureus). These bacteria are not necessarily any more virulent than strains that remain sensitive to antibiotics – the problem being that they are much more difficult to treat, particularly those which have become what is known as multidrug-resistance. Stricter regimes of hygiene in hospitals have been found to minimise the spread of MRSA, but it nevertheless represents a serious and ongoing problem for healthcare.

Multidrug-resistant Mycobacterium tuberculosis is another microbe becoming more common worldwide. As its name suggests, this bacterium is responsible for tuberculosis, a potentially fatal infectious disease of the respiratory system, which was thought to be under control through the use of antibiotics until the 1980s, when resistant strains began to emerge. Today, more than 100,000 people are thought to die every year as a consequence of this resistance – many of whom live on the African continent, where treatment may not be available and where, in some cases, those infected already have an immune system weakened by HIV.

Developing Solutions

One potential solution to antibiotic resistance would be the regular introduction of new classes of antibiotics to which pathogens have no resistance, but so far this has not happened. Big pharmaceutical companies, responsible for the design and introduction of most new drugs, have been reluctant to invest in developing new antibiotics because it is difficult and expensive, and antibiotics are not very lucrative compared to other classes of drugs. Patients usually only need antibiotics for about a week, and new ones would only remain effective for as long as it took for resistance to build up, which can take just a few years. Drugs for conditions such as heart disease, for example, are often used for long-term treatments so, once pharmaceutical companies have made the initial investment involved in development and clinical trials, they can expect to sell successful drugs for a much longer period.

In its 2014 report, the WHO identified serious gaps in available information on the types of antibiotic resistance occurring globally, which, together with a lack of coordination between countries, was impeding possible responses to what has become a serious problem. As well as stating that increased information gathering, and sharing is needed, the report recommended greater government investment in research, and the responsible use of antibiotics in medicine and agriculture. Everybody has a part to play, though, from doctors not overprescribing antibiotics to patients using them exactly as prescribed.

Alternative Theories

In January 2015, researchers at Northeastern University in Boston, Massachusetts, reported that they had discovered a new antibiotic named teixobactin, which they had isolated from the soil bacterium Eleftheria terrae through a new culturing method. It was the first new class of antibiotic to be found for almost 30 years, and in tests proved effective against a range of bacteria, including MRSA and Mycobacterium tuberculosis, neither of which appeared to develop resistance to it. Teixobactin works by inhibiting the production of those fats that form a constituent part of cell walls and preventing bacteria from growing, while most other antibiotics target proteins in the cell wall or inside the cell to kill fully grown bacteria. The research team thought that E. terrae might have developed this function in response to naturally occurring resistance.

If they are correct, resistance to teixobactin is less likely to develop in the first place and, even if it does, will take much longer to build up than resistance against existing antibiotics. Clinical trials should take about five years and, if it passes, the research team predicts that teixobactin could remain effective for over 30 years. Even if teixobactin fails these trials, this new method of culturing soil bacteria in the laboratory can be used to investigate the potential of many other species of bacteria to produce antibiotics. This on its own could lead to a whole new era in the fight against antibiotic resistance.

Standard